ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.656,81
0,91%
S&P 500
5.194,18
0,13%
Dow Jones
39.172,55
0,30%
Euro vs US Dollar
1,07662
0,18%
Bitcoin
61.353,00
0,27%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Cardiol Therapeutics Inc (CRDL)

  7. Cardiol Therapeutics Inc (CRDL) News

CRDL

Cardiol Therapeutics (CRDL)

Cardiol Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:CRDL
DatumZeitQuelleÜberschriftSymbolFirma
26/02/202416h06Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
21/02/202413h29Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
15/02/202419h15AllPennyStocks.comOrphan Drug Designation Sends Shares of this Dual-Listed Life Science Therapy Company SoaringNASDAQ:CRDLCardiol Therapeutics Inc
15/02/202413h30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
24/01/202413h29Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
09/01/202413h31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
05/12/202313h30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
16/11/202312h01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
01/11/202312h29Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
20/10/202323h01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
11/10/202316h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
10/10/202312h01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
26/09/202313h28Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
20/09/202316h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
19/09/202313h29Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
10/08/202323h13Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
09/08/202314h21Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
08/08/202313h38Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
29/06/202317h45Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CRDLCardiol Therapeutics Inc
29/06/202317h44Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
27/06/202313h29Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CRDLCardiol Therapeutics Inc
18/05/202322h04Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CRDLCardiol Therapeutics Inc
15/05/202322h55Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CRDLCardiol Therapeutics Inc
29/03/202313h29Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CRDLCardiol Therapeutics Inc
29/03/202312h02Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:CRDLCardiol Therapeutics Inc
07/03/202313h29Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CRDLCardiol Therapeutics Inc
12/12/202213h32Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CRDLCardiol Therapeutics Inc
20/11/202209h35TipRanksCardiol Therapeutics (CRDL) Receives a Rating Update from a Top AnalystNASDAQ:CRDLCardiol Therapeutics Inc
20/11/202209h15TipRanksCanaccord Genuity Sticks to Their Buy Rating for Cardiol Therapeutics (CRDL)NASDAQ:CRDLCardiol Therapeutics Inc
14/11/202223h35Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CRDLCardiol Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CRDL

Kürzlich von Ihnen besucht

TG
BAS
BASF
NASDAQ
AMZN
Amazon.com
AMEX
XLV
Health Care Select Sector
NYSE
MRK
Merck
NASDAQ
GOOGL
Alphabet
USOTC
ADDYY
Adidas (QX)
DBI
SDXP
SDAX
CCOM
US500
US 500
CCOM
SILVER
SILVER
FX
EURGBP
Euro vs Sterling
DBI
TDXP
Tec DAX
NYSE
MCD
McDonalds
TG
D7G
Nel ASA
USOTC
DTEGY
Deutsche Telekom (QX)
TG
TUI1
Tui
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten